IXICO (PHYOF) Other Operating Expense: $0.68 Mil (TTM As of Mar. 2026)


PHYOF IXICO PLC PHYOF
42 GF Score
Price $0.07
GF Value $0.06
! 2 Warning Signs
View Full Analysis

What is IXICO Other Operating Expense?

IXICO PHYOF -53.33% 42 Other Operating Expense is $0.68 Mil as of Mar. 2026. GuruFocus rates PHYOF with a GF Score™ of 42/100 and a GF Value™ of $0.06. The stock has 2 warning signs investors should review.

IXICO's Other Operating Expense for the six months ended in Mar. 2026 was $0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $0.68 Mil.

IXICO's quarterly Other Operating Expense increased from Mar. 2025 ($-0.37 Mil) to Sep. 2025 ($0.68 Mil) but then declined from Sep. 2025 ($0.68 Mil) to Mar. 2026 ($0.00 Mil).

IXICO's annual Other Operating Expense declined from Sep. 2023 ($0.04 Mil) to Sep. 2024 ($-0.70 Mil) but then increased from Sep. 2024 ($-0.70 Mil) to Sep. 2025 ($0.29 Mil).

IXICO Other Operating Expense Historical Data

* Premium members only.

The historical data trend for IXICO's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IXICO Other Operating Expense Chart

IXICO Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 -0.78 0.04 -0.70 0.29

IXICO Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.33 -0.36 -0.37 0.68 0.00
PHYOF
42GF Score
IXICO PLC PHYOF
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IXICO Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $0.68 Mil mean?
IXICO (PHYOF) has a Other Operating Expense of $0.68 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on IXICO and its competitors.
Is IXICO's Other Operating Expense too high?
IXICO's current Other Operating Expense is $0.68 Mil. Overall, IXICO has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does IXICO's Other Operating Expense compare to VRTX and REGN?
IXICO's Other Operating Expense of $0.68 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on IXICO and its competitors. IXICO's current Other Operating Expense is $0.68 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IXICO stock overvalued right now?
IXICO (PHYOF) has a current Other Operating Expense of $0.68 Mil. The stock's GF Value™ is $0.06, compared to a current price of $0.07 — trading 16.7% above its estimated fair value. The current Other Operating Expense is $0.68 Mil. IXICO's overall GF Score™ is 42/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For IXICO (PHYOF), the current Other Operating Expense is $0.68 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IXICO (PHYOF) Overvalued in 2026?

Based on GuruFocus' analysis, IXICO stock appears to be overvalued. The current stock price of $0.07 is trading 16.7% above its estimated GF Value™ of $0.06.

Key valuation signals for PHYOF:

  • Other Operating Expense: $0.68 Mil
  • GF Value™: $0.06 vs. price of $0.07 (16.7% above fair value)
  • GF Score™: 42/100 with 2 warning signs

No single metric tells the full story. See the PHYOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IXICO Business Description

Other Exchanges IXI:UK
Address 15 Long Lane, 4th Floor, Griffin Court, London, GBR, EC1A 9PN
IXICO PLC provides neuroscience imaging and biomarker analytics services, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring. It operates as an imaging contract research organization, supporting clinical trials for neurological disorders by processing and analyzing imaging data. Its platform is used to measure biomarkers associated with diseases such as Alzheimer's, Huntington's, and Parkinson's.
42GF Score

Get the complete analysis for PHYOF

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.07
Price
$0.06
GF Value